Meta‐analysis: colonoscopic post‐polypectomy bleeding in patients on continued clopidogrel therapy
Alimentary Pharmacology & Therapeutics2013Vol. 37(10), pp. 947–952
Citations Over TimeTop 10% of 2013 papers
Abstract
The results of this meta-analysis suggest that continued clopidogrel increases the risk of delayed but not immediate post-polypectomy bleeding. Clopidogrel interruption in individuals with coronary artery disease predisposes to serious acute ischaemic events. In high-risk patients, endoscopists should be cognisant of these risks and consider deferring elective colonoscopy and polypectomy until it is considered safe to interrupt clopidogrel therapy.
Related Papers
- → Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)(2010)58 cited
- → Follow-up of 3 Million Persons Undergoing Colonoscopy in Germany: Utilization of Repeat Colonoscopies and Polypectomies Within 10 Years(2020)12 cited
- → Role of clopidogrel in addition to aspirin in the prevention of recurrent ischaemic events in acute coronary syndrome with ST-segment elevation(2018)1 cited
- → Tu1004 Higher Quality Colonoscopy Is Associated With Significantly Greater Time Spent on Polypectomy(2017)
- → Mo1719 EFFECT OF WATER EXCHANGE METHOD ON ADENOMA MISS RATE OF PATIENTS UNDERGOING SELECTIVE POLYPECTOMY: A RANDOMIZED CONTROLLED TRIAL(2018)